{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:56Z","timestamp":1790820656934,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejpb.2016.10.023","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T17:45:45Z","timestamp":1478022345000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)"],"prefix":"10.1016","volume":"110","author":[{"given":"Malgorzata","family":"Sznitowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Wolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Baranska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Pietkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.10.023_b0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.10.023_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00403-011-1163-7","article-title":"Nanoparticles in dermatology","volume":"303","author":"Papakostas","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejpb.2016.10.023_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2009.12.005","article-title":"Targeting to the hair follicles: current status and potential","volume":"57","author":"Wosicka","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejpb.2016.10.023_b0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ijpharm.2015.09.068","article-title":"Roxithromycin-loaded lipid nanoparticles for follicular targeting","volume":"495","author":"Wosicka-Frackowiak","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Souto","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0035","first-page":"75","article-title":"Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications","volume":"2","author":"Jaspart","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.023_b0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijpharm.2015.08.059","article-title":"Design of lipid microparticle dispersions based on the physicochemical properties of the lipid and aqueous phase","volume":"494","author":"Lauterbach","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0045","first-page":"24","article-title":"Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles","volume":"66","author":"Pilaniya","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.10.023_b0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijpharm.2012.11.009","article-title":"Technology of stable, prolonged-release eye-drops containing cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM)","volume":"441","author":"Wolska","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0055","first-page":"375","article-title":"Preparation, characterization and physico-chemical properties of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): their benefits as colloidal drug carrier systems","volume":"61","author":"\u00dcner","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.10.023_b0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ejpb.2016.10.023_b0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.colsurfb.2011.07.036","article-title":"Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables","volume":"88","author":"Das","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2016.10.023_b0070","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s11095-007-9234-3","article-title":"Effect of Solid Lipid Nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-Hugag transfection","volume":"24","author":"Asasutjarit","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.10.023_b0075","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/jps.21854","article-title":"Solid lipid microparticles produced by spray congealing: influence of the atomizer on microparticle characteristics and mathematical modeling of the drug release","volume":"99","author":"Passerini","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.023_b0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2007.04.006","article-title":"Lipid nanoparticles for improved topical application of drugs for skin diseases","volume":"59","author":"Sch\u00e4fer-Korting","year":"2007","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ejpb.2016.10.023_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/02652040500435295","article-title":"Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencaps."},{"key":"10.1016\/j.ejpb.2016.10.023_b0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcis.2009.03.012","article-title":"Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)","volume":"334","author":"Helgason","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2016.10.023_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(96)04822-3","article-title":"Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles","volume":"148","author":"Cavalli","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","volume":"419","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ejpb.2007.04.019","article-title":"Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles","volume":"67","author":"Kuntsche","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt050227","article-title":"Preparation and in vivo toxicity study of Solid Lipid Microparticles as carrier for pulmonary administration","volume":"5","author":"Sanna","year":"2004","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ejpb.2016.10.023_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2005.11.038","article-title":"The expulsion of lipophilic drugs from the cores of solid lipid microparticles in diluted suspensions and in concentrates","volume":"310","author":"Pietkiewicz","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0130","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0009-2509(00)00458-9","article-title":"Crystallization behaviour of fats and lipids \u2013 a review","volume":"56","author":"Sato","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejpb.2016.10.023_b0135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.colsurfb.2011.07.036","article-title":"Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables","volume":"88","author":"Surajit","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2016.10.023_b0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion","volume":"29","author":"Huang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejpb.2016.10.023_b0145","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jps.10413","article-title":"Influence of emulsifiers on the crystallization of solid lipid nanoparticles","volume":"92","author":"Bunjes","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.023_b0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(03)00229-1","article-title":"Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets","volume":"260","author":"Hamdani","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","article-title":"Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase","volume":"47","author":"Freitas","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5173(94)00347-8","article-title":"Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?","volume":"115","author":"Westesen","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0170","first-page":"325","article-title":"The choice of lipids and surfactants for injectable extravenous microspheres","volume":"59","author":"Pietkiewicz","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2016.10.023_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"G\u00f6kce","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.023_b0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2010.12.024","article-title":"The size of solid lipid nanoparticles: an interpretation from experimental design","volume":"84","author":"Vitorino","year":"2011","journal-title":"Colloids Surf. B"},{"issue":"8","key":"10.1016\/j.ejpb.2016.10.023_b0185","first-page":"10","article-title":"Ethylhexylglycerin for improved skin feel","volume":"138","author":"Leschke","year":"2010","journal-title":"SOFW-Journal"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T02:03:12Z","timestamp":1568512992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116307603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"alternative-id":["S0939641116307603"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.023","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}